Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)
Location: Dallas TX, St Louis MO, Indianapolis IN, Chicago IL,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0+
Code: NCT05750498
Recruiting
A Study of Alisertib in Patients With Extensive Stage Small Cell Lung Cancer
for
Small Cell Lung Cancer
Location: Dallas TX, Daphne AL, Grand Island NE, Nashville TN,
Sponsor: Puma Biotechnology, Inc.
Sex: All
Age: 18+
Code: NCT06095505
Phase 2, Recruiting
A Study of Tegavivint (BC2059) in Patients With Advanced Hepatocellular Carcinoma
for
Advanced Hepatocellular Carcinoma
Location: Dallas TX, Houston TX, Chicago IL, Charlotte NC,
Sponsor: Iterion Therapeutics
Sex: All
Age: 18+
Code: NCT05797805
Phase 1, Phase 2, Recruiting
A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery
for
Coagulation Disorder
Location: Dallas TX, Tulsa OK, Arkansas City AR, Englewood CO,
Sponsor: Takeda
Sex: All
Age: 18+
Code: NCT05156983
Phase 3, Recruiting
A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma
for
Renal Cell Carcinoma
Location: Dallas TX, Lubbock TX, St Louis MO, Nashville TN,
Sponsor: HiberCell, Inc.
Sex: All
Age: 18+
Code: NCT06234605
Phase 1, Recruiting
A Long-term, Post-marketing Safety Study of Palynziq in Patients With PKU (PALace)
for
Phenylketonuria (PKU)
Location: Dallas TX, New Orleans LA, Nashville TN, Aurora CO,
Sponsor: BioMarin Pharmaceutical
Sex: All
Age: 0+
Code: NCT05813678
Recruiting
A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections
for
Neutropenia
Location: Dallas TX, Fort Worth TX, Houston TX, Memphis TN,
Sponsor: X4 Pharmaceuticals
Sex: All
Age: 12+
Code: NCT06056297
Phase 3, Recruiting
AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF
for
Symptomatic Heart Failure With Preserved Ejection Fraction (HFpEF),
Location: Dallas TX, Houston TX, Little Rock AR, St Louis MO,
Sponsor: Cytokinetics
Sex: All
Age: 40 - 70+
Code: NCT06793371
Phase 2, Recruiting
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
for
Chronic Graft-Versus-Host Disease (cGVHD)
Location: Dallas TX, Austin TX, Westwood KS, St Louis MO,
Sponsor: The University of Texas Health Science Center, Houston
Sex: All
Age: 18+
Code: NCT05958654
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
for
Multiple Myeloma
Location: Dallas TX, Atlanta GA, Indianapolis IN, Rochester MN,